GeneDx Holdings Corp.
Rank #48HypergrowthWGS · Nasdaq · Healthcare
GeneDx Holdings Corp. (WGS) — Rank #48 by gross profitability (GP/assets 0.62) · ROE -8.6% · Piotroski F-Score 6 / 9.
As-of 2026-09-15 · CIK 0001818331 · all metrics point-in-time as of the filing date.
About
GeneDx Holdings Corp., a genomics company, provides genetic testing services.
Show moreShow less
The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp.
was founded in 2000 and is headquartered in Stamford, Connecticut.
- Industry
- Diagnostics & Research
- Sector
- Healthcare
- State
- DE
- Filer Category
- Large accelerated filer
- Fiscal Year End
- December 31
- Website
- genedx.com
Segments
A revenue-by-segment breakdown is not available for WGS. This is expected for a single-reportable-segment filer with no product/service revenue disaggregation, or for a company whose filings predate SEC’s XBRL viewer.